Will Hims & Hers Health stock face deeper losses as weak momentum dominates?

Traders Union
All News
Stocks
Hims & Hers Health drops 9.74% today

Highlights

Hims & Hers Health expanded its Benefits platform to 14 partners, including services supporting GLP-1 weight loss subscribers.
Company stock saw a subdued price move despite the expansion, and third-quarter earnings are scheduled for November 9, 2026.
Shares of Hims & Hers Health declined 9.74% to $24.06 with technical indicators aligning bearishly, and the likely price range is $21.53 to $26.59 in the coming days.

Platform expansion met with muted reaction as earnings approach

Hims & Hers Health, Inc. expanded its Benefits platform on November 5, 2026, by adding four new partners—Grüns, Medjet, Tonal, and Viome—bringing the total program count to 14, according to Yahoo Finance. This expansion increases the range of health support services available to subscribers, notably enhancing options for those on a GLP-1 weight loss journey, but the development was accompanied by muted price reaction amid broader market movement. Additionally, Hims & Hers Health is set to release its third-quarter earnings on November 9, 2026, which may contribute to heightened anticipation and near-term volatility.

Sustained downside bias as technical signals remain bearish

On the technical front, HIMS is currently trading below its MA-20 at $25.52, MA-50 at $27.09, and MA-200 at $26.93 on the hourly chart. The nearest resistance lies at the Ichimoku Kijun level of $25.77. Both MACD and ADX generate a sell signal, while RSI, Stoch RSI, and CCI are all in neutral zones, not indicating overbought or oversold conditions. Bull/Bear Power is negative at -0.69, pointing to intraday seller dominance, while the Awesome Oscillator remains inconclusive, and price action shows a downward gap of 0.35 on elevated volatility.

Consolidation expected amid high downside probability and tight range

Over the next several days, HIMS is forecasted to trade in a volatility band between $21.53 and $26.59. The likelihood of further downside movement stands at 77%, compared to a 23% probability of upward movement. Baseline expectations call for consolidation within this range. A breakout above $25.77 would open the door for a move toward $26.59, while a decisive drop below support at $21.53 could trigger additional downside pressure.

Viktoras Karapetjanc, analyst at Traders Union, sees Hims & Hers Health as fundamentally enhancing its platform with new partnerships, broadening its integrated healthcare offerings. He acknowledges that the stock remains under downside pressure, but expects platform expansion to support long-term retention and interest. Anticipation is also building around the upcoming earnings report, adding to near-term volatility. Karapetjanc believes current weakness is a tactical opportunity for patient investors. "With strategic partnerships expanding and earnings ahead, I see long-term upside potential despite the short-term volatility."

Earlier, analysts noted that Hims & Hers Health remained under persistent technical and legal headwinds, limiting its ability to stage a meaningful rebound. With the stock now trading deeper below key averages and new volatility bands established, traders should closely monitor the $21.53 support level, where a sustained breakdown could accelerate downside momentum.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.